Stocks 11 May 2026 - 21 May 2026

Liquidia Sinks 5% After Recent Rally
····

Liquidia Sinks 5% After Recent Rally

Liquidia Corporation shares were flat in early trading Tuesday after falling hard the day before. Investors are watching for more news from the company on YUTREPIA, its inhaled drug for lung disease. The Nasdaq stock ended Monday at $58.75, off 5.04%, and was last seen at $58.91 in thin premarket action at 6:22 a.m. EDT, according to MarketWatch. Liquidia has been a top biotech pick for 2026, with the stock gaining about 70% year to date through Monday, Yahoo Finance data show. Shares touched an intraday high of $63.46 last week before pulling back.
June 2, 2026
CEVA Stock Is Near a Breakout: The AI Licensing Signal Traders Are Watching
····

CEVA Stock Is Near a Breakout: The AI Licensing Signal Traders Are Watching

CEVA, Inc. shares held near their highest levels in a year before Thursday’s open, last quoted around $38 after a 4.4% jump in the prior session. The Nasdaq-listed chip-licensing company closed Wednesday at $38.03, while StockAnalysis showed it indicated at $37.98 in pre-market trade at 5:14 a.m. EDT, below a 52-week high of $39.94. The timing matters because the regular Nasdaq session had not yet opened, leaving the early move to thinner pre-market trading. Nasdaq lists pre-market trading from 4:00 a.m. to 9:30 a.m. Eastern, regular trading from 9:30 a.m. to 4:00 p.m., and the next U.S. market closure as Memorial Day on May 25.
May 21, 2026
AMOD Stock Alert: Alpha Modus’ Android Launch Puts This Tiny Fintech Bet on the Clock
····

AMOD Stock Alert: Alpha Modus’ Android Launch Puts This Tiny Fintech Bet on the Clock

Alpha Modus Holdings Inc.’s AMOD shares hovered near 20 cents early Thursday after the company said its Alpha Cash financial app had gone live on Android, a small product milestone for a Nasdaq-listed stock still under heavy pressure. The shares closed Wednesday at $0.20, down 5.09%, and were quoted at $0.21 in extended trading as of 4:29 a.m. Eastern. The timing matters because Alpha Modus is trying to turn a string of fintech announcements into measurable distribution and revenue. The company said Wednesday that Google Play availability completed the app’s rollout across both iOS and Android, one day before a regular U.S. trading session; Nasdaq’s 2026 holiday calendar lists the next full closure as Memorial Day on May 25.
May 21, 2026
Jaguar Health Shares Spike After 816% Revenue Jump, But Trial Results Still Key
····

Jaguar Health Shares Spike After 816% Revenue Jump, But Trial Results Still Key

Jaguar Health Inc. shares rose Wednesday as the small drugmaker posted an 816% surge in first-quarter revenue. The bump came after a licensing deal that transferred U.S. commercial rights for Mytesi and Canalevia-CA1 to Woodward Specialty, which is linked to privately held Future Pak. Shares finished the day at $3.67, gaining 9.2% from $3.36 on Tuesday. Trading volume jumped to 593,152 shares from 69,266, Jaguar’s LSEG-based price table showed.
May 21, 2026
Akebia Shares Bounce 12% After Volatile Session
····

Akebia Shares Bounce 12% After Volatile Session

Akebia Therapeutics shares rallied in late U.S. trading Wednesday, clawing back after falling for two straight sessions. Investors moved into select smaller biotech stocks. Akebia was last at $1.01, up roughly 12%. Shares earlier dipped to an intraday low of 89.32 cents. AKBA’s trading looks less like a reaction to earnings and more like a bet on Vafseo, its new anemia drug. Shares finished Monday at $1.01, then slipped to 90 cents on Tuesday, according to LSEG data on the company’s investor page.
May 21, 2026
HeartCore Cash Concerns Leave HTCR Shares Flat
····

HeartCore Cash Concerns Leave HTCR Shares Flat

HeartCore Enterprises Inc. was last seen at $2.70 in after-hours trading Wednesday, up 2 cents. The microcap hovered near its lows, holding a market cap of about $3.4 million. Most recent trade was at 4:45 p.m. EDT. Trading volume was light. Just 23,040 shares changed hands, far below the typical 52,270 average. With less activity, smaller trades had a bigger impact on price.
May 20, 2026
Why Revelation Biosciences Stock Jumped Today as Traders Eye Its Kidney-Drug Bet
····

Why Revelation Biosciences Stock Jumped Today as Traders Eye Its Kidney-Drug Bet

Revelation Biosciences shares were quoted at $1.09 after the U.S. market close on Wednesday, up $0.06, or 5.82%, giving the clinical-stage biotech a market value of about $4.1 million. The move beat a firmer Nasdaq session, with the broader index up about 1.55% late in the day. The gain was not a catch-up trade after a holiday. Nasdaq’s 2026 calendar lists Memorial Day on May 25 as the next U.S. market closure, leaving Wednesday as a regular trading session for REVB.
May 20, 2026
Krispy Kreme Stock Pops as DNUT’s Turnaround Faces Its Next Test
·····

Krispy Kreme Stock Pops as DNUT’s Turnaround Faces Its Next Test

Krispy Kreme shares rose 14 cents, or about 4.4%, to $3.35 in Wednesday afternoon trading, outpacing broader U.S. stock trackers as former partner McDonald’s traded little changed. The S&P 500 tracker SPY was up about 0.8%, while the Nasdaq-100 tracker QQQ gained about 1.3%. The move puts a familiar question back in front of investors: whether Krispy Kreme can turn brand heat into steadier cash generation. For DNUT, the flavor cycle is not the whole story. The balance sheet is.
May 20, 2026
Pilbara Minerals Slides as Lithium Rally Faces Supply Hurdle
····

Pilbara Minerals Slides as Lithium Rally Faces Supply Hurdle

PLS Group Limited finished Tuesday at A$5.92, falling 1.33%. The ASX lithium producer sits 8.92% under its 52-week high from May 12, after a steep recovery from last year’s low. The Australian Securities Exchange remained closed, with the next session set for Wednesday from 9:59 a.m. to 4 p.m. Sydney time. The pullback was notable since the rest of the market was stronger. The S&P/ASX 200 gained 1.17%—up 99.4 points to 8,604.70—on Tuesday, with Australian shares rebounding after Monday’s slide.
May 19, 2026
Macquarie drops Monday as dividend looms, ASX losses widen
····

Macquarie drops Monday as dividend looms, ASX losses widen

Macquarie Group ended Monday at A$236.55, slipping as the shares traded ex-dividend and the Australian market fell to a seven-week low. The stock moved between A$234.88 and A$238.82, according to Google Finance. Timing was key. Macquarie shares went ex-dividend on Monday, so new buyers missed out on the declared payout. The FY26 final dividend is A$4.20 per share, with 35% of it franked. That’s the portion carrying Australian tax credits. The record date is May 19. Payment is set for July 2.
May 18, 2026
Diageo Shares Gain as Guinness Parent Faces New Turnaround Test
····

Diageo Shares Gain as Guinness Parent Faces New Turnaround Test

Diageo shares climbed in London on Monday, with the stock adding to a hard-fought rally for the Guinness and Johnnie Walker maker as a director bought shares and U.S. spirits demand stayed soft. Shares were at 1,553 pence, up 1.54% as of 3:08 p.m. in London. The FTSE 100 edged higher. But the stock is still trading roughly 30% under its 52-week peak of 2,215 pence, with management still under pressure to prove the gains aren’t just a short-term move.
May 18, 2026
Shell Rises with Oil Back at $110
····

Shell Rises with Oil Back at $110

Shell Plc climbed in London on Monday, beating the FTSE 100. Rising Gulf tensions sent crude up, bringing investors into big oil stocks. Shell traded at about 3,247 pence on delayed quotes, 52.5p higher, up 1.64%. The FTSE 100 added 0.26%. Shell closed at 3,194.5p before and opened Monday at 3,214p.
May 18, 2026
Ampol approaches 52-week high as investors bet on refinery margins ahead of ASX open
···

Ampol approaches 52-week high as investors bet on refinery margins ahead of ASX open

Ampol Ltd is trading close to a one-year high as it starts the ASX week, with shares jumping on Friday. Investors zeroed in on Lytton refinery numbers and waited for a regulator decision on the company’s planned EG Australia buy. Ampol shares ended Friday at A$35.05, up 2.88% on the day. Volume came in near 1.96 million shares. The stock closed around 2.5% higher for the week, putting it close to its 52-week high of A$36.04.
May 17, 2026
Hiscox Rallies After Bid Chatter, All Eyes on Monday
·····

Hiscox Rallies After Bid Chatter, All Eyes on Monday

Hiscox Ltd stock started the week with a takeover premium priced in after jumping on Friday. Shares finished at 1,841p, up 202p, or 12.32%. The move followed reports Canada’s Intact Financial Corp is looking at a bid. The five-day gain landed at 13.36%, according to MarketScreener. Hiscox traded higher even as broader London shares came under pressure. Reuters data had the FTSE 100 off 1.71% on Friday, and UK stocks dropped with investors fretting about political uncertainty, the bond market, and rising oil.
May 16, 2026
BAE Systems Stock Drops; Traders Watching Upcoming Sessions
····

BAE Systems Stock Drops; Traders Watching Upcoming Sessions

BAE Systems shares slid 3.77% to 1,850.50 pence on Friday, underperforming the FTSE 100, which lost 1.71%. Markets are now closed for the weekend. Investors are left debating if this was just a fleeting risk-off move or something bigger for defence stocks. BAE ended a down week with more losses. Shares dropped roughly 4.3% from last Friday’s finish at 1,933.80p. The FTSE 100 lost less than half a percent in the same stretch.
May 16, 2026
Cochlear Shares Drop Again As Investors Question the Profit Shock
····

Cochlear Shares Drop Again As Investors Question the Profit Shock

Cochlear Ltd dropped 4.64% to A$95.42 on Thursday, stretching its decline to a third straight session and leaving the Australian hearing-implant maker close to lows reached during last month’s record slide. Volume spiked, too—roughly 671,000 shares changed hands, up from 351,000 the previous day. This shift lands hard for investors still wrestling with how to value a name that used to be pegged as a reliable health-care growth play. Back on April 22, Reuters said Cochlear shares cratered 40.7%—the worst single-day performance the stock’s ever posted—after the company slashed its full-year profit outlook and pointed to sluggish demand in developed markets, Middle East unrest, and currency headwinds.
May 15, 2026
Rentokil Stock Edges Higher, But North America Is Still The Test Investors Cannot Ignore
····

Rentokil Stock Edges Higher, But North America Is Still The Test Investors Cannot Ignore

Rentokil Initial plc shares ticked up in London Thursday, recovering a slice of this week’s drop as some investors latched onto hints of a North America rebound—even as the U.S. pest-control market remains tough. The stock was last up 0.63% at 476.90p as of 15:03 BST. The FTSE All-Share, for its part, gained 0.21%, according to Fidelity data. This shift is key: Rentokil’s narrative has tightened. The debate isn’t about pest control’s staying power anymore. It’s about whether the new leadership team can get things right in North America—a region that’s shouldered the bulk of the pressure ever since the Terminix acquisition changed Rentokil’s shape.
May 14, 2026
Vodafone Share Price Slips After Earnings: Three UK Deal and UBS Sell Call Raise the Stakes
····

Vodafone Share Price Slips After Earnings: Three UK Deal and UBS Sell Call Raise the Stakes

Vodafone slipped 3.0% to 116.80 pence in London morning action on Tuesday, despite the telecoms company projecting improved earnings for the coming year and pointing to a streamlined business after a three-year shakeup. On Monday, the shares hit their highest mark since August 2022. The stakes are rising as investors look to see if Vodafone’s rapid share-price surge holds up through CEO Margherita Della Valle’s next act: taking full command of VodafoneThree in the UK, turning things around in Germany, and keeping cash returns flowing. The company has already shed weaker businesses in Spain, Italy, and the Netherlands—now, it’s doubling down on Germany, the UK, and Africa.
May 12, 2026
Hannover Re Stock Drops After 48% Profit Jump as Price Pressure Bites
····

Hannover Re Stock Drops After 48% Profit Jump as Price Pressure Bites

Shares in Hannover Re slipped on Monday, down 2.25% to 239.10 euros by mid-afternoon, MarketScreener data showed, despite a 48% surge in first-quarter earnings. Investors shrugged off a quarter with fewer claims, zeroing in instead on the subdued pricing environment in property-and-casualty reinsurance. Pricing power is under strain. In its April treaty renewals—where insurers secure protection for blocks of risk—Hannover Re reported a 3.6% drop in risk-adjusted prices. Swiss Re, the bigger player, logged price declines in those same April renewals, driving home that this squeeze extends beyond Hannover Re.
May 11, 2026
1 2 3 4 5 … 9